Trials / Completed
CompletedNCT01064219
Intrauterine Human Chorionic Gonadotrophins (hCG) and Endometrial Treg Cells
The Effect of Intrauterine Injection of Human Chorionic Gonadotrophins (hCG) on the Endometrial T-regulatory Cells and the Electronmicroscopic Endometrial Characteristics
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- The Egyptian IVF-ET Center · Academic / Other
- Sex
- Female
- Age
- 20 Years – 38 Years
- Healthy volunteers
- Not accepted
Summary
Intrauterine injection of hCG around the time of implantation may increase endometrial Treg cells and improve implantation. It has been demonstrated that regulatory T cells expand during pregnancy. hCG was found to be secreted by the embryo immediately after fertilization and has chemoattractant properties to Treg cells.
Detailed description
Aim of the work: To study the effect of intrauterine injection of human chorionic gonadotrophin on the endometrial T regulatory cells (Treg cells)and the electromicroscopic endometrial characteristics. Background: It has been demonstrated that regulatory T cells expand during pregnancy and are present at the feto-maternal interface at very early stages in pregnancy. Rational: Intrauterine injection of hCG around the time of implantation may increase endometrial Treg cells and improve implantation. Methods: Intrauterine injection of 100 IU hCG will be done followed by endometrial biopsy to check for Treg cells and pinopodes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | human chorionic gonadotrophin | intrauterine injection of 100 IU hCG followed by endometrial biopsy . |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2010-02-08
- Last updated
- 2013-11-05
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT01064219. Inclusion in this directory is not an endorsement.